Back to VRSK
VRSK: subscription growth offsets margin pressure
$VRSKNEUTRALTechnology

VRSK: subscription growth offsets margin pressure

Verisk ($VRSK) reported a Q3 2026 beat driven by subscription and transactional strength, yet valuation and cash‑flow trends leave upside modest versus consensus targets. This report examines fundamentals, valuation, catalysts and key risks as of Friday, November 6, 2026.

November 7, 202610 min read
Current Price
$204.59
-3.25%
Analyst Rating
Buy
Price Target
$222.86
8.9% upside
P/E Ratio
31.00

Executive Summary

Investment Thesis: Verisk ($VRSK) continues to execute a subscription-led model that drove a Q3 2026 revenue increase and an adjusted EPS beat, supporting margin expansion. The business generates strong operating cash flow and high gross margins, reflecting data and analytics pricing power. However, free cash flow showed weakness and the company carries elevated net leverage relative to cash on hand, which combined with a high multiple compresses near-term upside. For investors, the tradeoff is stable, lower-beta growth against valuation and balance-sheet considerations.

Current Price: $204.59 (as of Friday, November 6) | Key Metric: P/E 31.0 | Stance: NEUTRAL

Company Overview

Verisk Analytics, Inc. provides data analytics and software solutions, primarily for insurance, reinsurance and related risk-analytics markets globally. The company packages underwriting, pricing, claims and catastrophe modeling tools into subscription and transactional offerings that target insurers, brokers and other risk-bearing organizations.

Key Products & Competitive Position

  • Core Business: Recurring subscription services and transactional data analytics for insurance underwriting, claims and risk modeling.
  • Key Products: Underwriting tools, loss cost and rating services, catastrophe models, claims analytics, life-insurance underwriting solutions, and regulatory/compliance data sets.
  • Competitive Moat: Deep industry-specific data, long-term client relationships, regulatory embeddedness in rating and loss-cost workflows, and proprietary modeling IP.

Recent Developments

Verisk reported Q3 2026 results on November 5, 2026, with subscription growth and stronger transactional revenue cited on the earnings call. Management highlighted margin expansion driven by operating leverage, even as free cash flow declined year over year. Analysts have largely maintained a Buy consensus with mixed target revisions in the days following the release.

Financial Snapshot

Market Cap$26.63B
P/E Ratio31.0
52-Week Range$155.94 - $227.16
Dividend Yield0.95%
EPS (TTM)$6.81
ROE-111.25%

Revenue & Earnings Trends

For the trailing twelve months Verisk reported roughly $3.18B in revenue and EBITDA near $1.53B, implying robust margins for a software/data company. Revenue growth has been modestly positive, near 5% year over year, driven by subscription renewals and an uptick in transactional sales. Q3 2026 produced an adjusted EPS of $1.96 versus consensus $1.92, signaling continued margin control, though management flagged weaker free cash flow in the quarter.

Balance Sheet Highlights

Verisk carries total debt around $4.63B and cash near $557M. The current ratio is 1.07 and quick ratio about 0.95, showing liquidity is available but not abundant. Net leverage is meaningful after accounting for cash, and the negative ROE figure points to accounting impacts, likely related to shareholder capital changes and buybacks rather than operating impairment. You should watch leverage metrics if capital allocation or M&A plans are part of management commentary.

Valuation Analysis

Current Valuation Metrics

Forward P/E31.0vs Industry: mid-20s
PEG Ratio~5.7Growth-adjusted
EV/EBITDA~20.0vs Historical: higher than long-term average
P/S Ratio~8.4vs Peers: premium

Historical Comparison

The current earnings multiple sits above many legacy data providers and the company's own long-term median. That premium reflects recurring revenue quality, high gross margins and strong customer retention, but it also implies investors are paying for steady growth and margin stability. With recent revenue growth in the mid-single digits, multiples look demanding relative to growth expectations.

Fair Value Estimate

Using consensus price targets (mean ~$222.86) and a multiples-based check (EV/EBITDA and forward P/E relative to peers), an illustrative fair-value range centers near $215–$225. That range assumes mid-single-digit organic revenue growth and continued margin maintenance. The implied upside from current levels is modest, so valuation sensitivity to slower cash flow or higher leverage is material.

Competitive Landscape

Market Position

Market Share: Meaningful in insurance data and analytics verticals | Ranking: Top-tier provider in risk analytics and underwriting solutions

Key Competitors

S&P Global (SPGI)S&P Global, data and analytics across financial markets and benchmarks
Moody's (MCO)Moody's, credit and risk analytics, data services
$TRUTransUnion, consumer and commercial data analytics with some overlap

Competitive Advantages

  • Moat 1: Proprietary, high-quality insurance data and long historical records that are costly to replicate.
  • Moat 2: Embedded workflows and regulatory reliance that drive high retention and predictable renewals.
  • Moat 3: Technical IP in catastrophe modeling and actuarial tools that are sticky and mission-critical for clients.

Earnings Track Record

Last 4 Quarters: 3 beats / 1 miss

Recent Earnings History

Q3 2026$1.96 vs $1.92 estBEAT
Q2 2026(quarterly results showed modest revenue growth, margin expansion)BEAT / IN LINE
Q1 2026(operating metrics held, subscription growth noted)BEAT / IN LINE
Q4 2025(one quarter with softer metrics versus certain estimates)MISS

Guidance Trend

Management commentary on the Q3 call emphasized continued subscription momentum and margin leverage. Free cash flow weakness was acknowledged and will be the focus of near-term guidance adjustments, if trends continue. Analysts will likely watch FY2027 guidance updates for updated free cash flow and organic growth assumptions.

Analyst Sentiment

Consensus Rating: Buy

Strong Buy: 4 Buy: 7 Hold: 8 Sell: 0

Price Targets

  • Low: $185
  • Mean: $222.86 (+8.9% upside)
  • High: $247

Recent Analyst Actions

Following Q3 commentary, most analysts reiterated Buy/Outperform stance while some revised estimates to reflect cash flow pressure. The consensus mean target sits near $223, which implies limited upside from current prices and leaves room for target compression if free cash flow or growth disappoints.

Recent News & Catalysts

Key Developments

  • Q3 2026 Earnings Beat: Verisk reported adjusted EPS $1.96 on November 5, 2026, topping consensus and showing revenue growth near 5% year over year, led by subscriptions and transactional sales.
  • Earnings Call Takeaways: Management cited subscription momentum and margin expansion, while noting a sharper-than-expected decline in cash flow that warrants monitoring.
  • Analyst Reaction: Coverage remained broadly positive in tone, with consensus rating Buy and mean targets implying modest upside.

Upcoming Catalysts

Next Earnings: Next quarterly report expected in early 2027 | Key Events: FY2027 guidance update, free cash flow trajectory, any capital allocation announcements, and commentary on transactional revenue sustainability.

Technical Outlook

Current Price: $204.59 vs 52-Week High: $227.16 (-9.9% from high)

Trend Analysis

Heading into the long weekend, $VRSK trades below its 52-week peak after a post-earnings pullback on November 6. The stock has recovered from the 52-week low of $155.94 earlier in the year, showing resilience on multi-month time frames. The lower beta (0.69) suggests price moves tend to be smoother than the broader market, which matters if you prefer lower-volatility exposure.

Key Levels

  • Resistance: $225, $235
  • Support: $200, $180

Bull vs Bear Case

Bull Case

  • Catalyst 1: Continued subscription growth and cross-sell into insurance workflows that sustain mid-single-digit revenue growth and expand margins.
  • Catalyst 2: Improvement in free cash flow and disciplined capital allocation, which could narrow the valuation premium.
  • Catalyst 3: Analyst upgrades and favorable macro conditions for insurance pricing, which could drive multiple expansion.

Bull Target: $247 (+20.8%)

Bear Case

  • Risk 1: Continued deterioration in free cash flow that forces downward estimate revisions and compresses multiples.
  • Risk 2: Balance-sheet pressure if leverage rises or if larger M&A uses debt without offsetting EBITDA gains.
  • Risk 3: Growth cooling below mid-single digits leaves the stock trading at a premium to peers without the growth justification.

Bear Target: $185 (-9.5%)

Risks to Consider

  • Valuation Risk: High P/E, EV/EBITDA and P/S multiples require continued execution to avoid multiple contraction if growth slips.
  • Competitive Risk: Large data vendors and niche analytics firms could apply pricing pressure or win share in specific verticals.
  • Macro Risk: Insurance industry cycles and catastrophe frequency can influence demand for certain Verisk products and transactional revenues.
  • Execution Risk: Free cash flow volatility and any missteps in integrating acquisitions or rolling out new products could hurt margins and capital allocation flexibility.

Bottom Line

Investment Verdict: NEUTRAL

Verisk remains a leading data and analytics provider with a resilient subscription model and high operating margins. The Q3 2026 beat reinforces operational strength, but cash-flow softness and a premium valuation compress the margin for error. Analysts generally favor the name, yet implied upside from consensus targets is limited relative to the stock's valuation sensitivity.

Action Items for Investors

  • Long-term investors: Monitor free cash flow stabilization and leverage metrics, and consider valuation sensitivity before adjusting exposure.
  • Short-term traders: Watch reaction to upcoming guidance and near-term support at $200 and $180 for tactical positioning.
  • Risk management: Track debt levels and any guidance changes that impact FCF and EBITDA; use position sizing to account for limited upside and event risk.

What to Watch This Week

  • Analyst note updates and target revisions following the Q3 release.
  • Management commentary on free cash flow trends and capital allocation in upcoming presentations.
  • Industry signals from insurers on premium rates and claim trends that could influence transactional revenue.

Share this report

Share this article

Spread the word on social media

Think VRSK will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.